Effect of Hip Versus Spinal Joint Mobilization on Hip Muscle Strength

NCT02700594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2016-03-07

No results posted yet for this study

Summary

Patients with painful knee conditions often present with hip muscle weakness. This weakness can lead to, and perpetuate, knee problems. Diminished strength causes movement impairments that can lead to pathology, functional limitations and disablement. In some cases, this hip muscle weakness is not caused by simple disuse and muscle shrinkage (atrophy). Hip weakness may be caused by an inhibitory mechanism that limits the force output of a muscle. The inhibition is reflexive and is in response to pain or joint dysfunction. Joint mobilization/manipulation can quickly reduce pain and improve joint function, possibly decreasing inhibition and increasing strength. Joint mobilization/manipulation may facilitate strength recovery. By restoring strength sooner, the patient may avoid the deleterious effects of prolonged muscle weakness and achieve quicker or better outcomes.

Conditions

  • Joint; Derangement, Knee

Interventions

OTHER

Joint mobilization

Mobilization and manipulation are manual therapy techniques" comprising a continuum of skilled passive movements to the joints and/or related soft tissues that are applied at varying speeds and amplitudes, including a small-amplitude/high- velocity therapeutic movement."16 The term joint mobilization, or nonthrust mobilization, often refers to slow, "rhythmic, repetitive passive movements to the patients' tolerance, in voluntary and/or accessory range and graded according to examination findings."

Sponsors & Collaborators

Principal Investigators

  • Angela Stolfi, DPT · Rusk PT Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-07-31
Completion
2014-07-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02700594 on ClinicalTrials.gov